Boston Scientific Corp
Close on Nov 20, 2026Market cap $60.84BP/E 17.0Yield –
Boston Scientific Trailing 12-Month (TTM) GAAP EBITDA by Quarter
Trailing 12-Month (TTM) GAAP EBITDA ($M) ($M)
Boston Scientific Trailing 12-Month (TTM) GAAP EBITDA: $5,419M in Q3 2026, up 10.1% from a year earlier.
Where the Q3 2026 figure comes from
“EBITDA 1,141 1,588 1,500 1,191 $ 5,419”
Source: BSX FY2026Q3 Financial & Operational Highlights Presentation ↗
Reported in Quarterly FOH Appendix C.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Boston Scientific Trailing 12-Month (TTM) GAAP EBITDA ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-ttm-gaap-ebitda
See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?